Navigating Cigna Ultomiris Prior Authorization
Streamlining Cigna Ultomiris prior authorization is critical for ensuring timely patient access to this high-volume specialty medication while optimizing revenue cycle performance.
For revenue cycle directors and prior authorization coordinators, understanding the specific pathways for specialty drugs like Ultomiris under Cigna Healthcare is essential. The process involves distinct channels for medical and pharmacy benefits, often leveraging different entities within The Cigna Group's ecosystem. Klivira integrates with these systems to automate submission and tracking, reducing administrative burden.
Cigna Healthcare Prior Authorization Channels for Ultomiris
Ultomiris, as a specialty medication, may fall under either Cigna Healthcare's medical or pharmacy benefit, dictating the prior authorization submission channel. For medical benefit PAs, submissions are primarily routed through CignaforHCP.com, the dedicated provider portal, or via X12 278 transactions through clearinghouses. Pharmacy benefit PAs, managed by Evernorth's Express Scripts, typically utilize Express Scripts' provider PA system or ePA platforms like CoverMyMeds and Surescripts.
The Role of Express Scripts and Accredo in Ultomiris PA
Evernorth, The Cigna Group's health services brand, plays a central role in pharmacy benefit management. Express Scripts is the PBM for Cigna's pharmacy benefit, handling retail PA submissions. For specialty drugs like Ultomiris, especially injectables, Accredo, the specialty pharmacy under Express Scripts, manages specific PA pathways and fulfillment. Understanding this distinction is key for accurate submission and follow-up.
Key Submission Considerations for Ultomiris with Cigna
- **Medical Benefit**: Submit via CignaforHCP.com or X12 278 for medical-administered Ultomiris.
- **Pharmacy Benefit**: Route through Express Scripts' PA system or ePA partners (CoverMyMeds, Surescripts) for pharmacy-dispensed Ultomiris.
- **Specialty Pharmacy**: Accredo handles specific specialty injectable PAs under the pharmacy benefit.
- **Policy Access**: Consult Cigna Healthcare's public provider site for the latest coverage policies and medical-necessity guidelines, referencing specific policy numbers and effective dates.
- **Documentation**: Ensure all clinical indications, site-of-care requirements, and prior therapy documentation align with Cigna's published criteria.
Turnaround Times and CMS-0057-F Compliance
Cigna Healthcare's prior authorization turnaround times are governed by state-mandated minimums for commercial plans and payer-published service-level targets. For Medicare Advantage and Qualified Health Plans on the Federal Facilitated Marketplace, Cigna is an impacted payer under CMS-0057-F, which mandates 72-hour standard and 24-hour expedited PA timeframes on a phased compliance timeline. Klivira's automation helps track these critical deadlines.
Common Denial Reasons and Appeal Pathways
Denials for Ultomiris under Cigna Healthcare often stem from medical necessity criteria not met, insufficient documentation, step therapy requirements, site-of-service mismatches, or non-formulary pharmacy issues through Express Scripts. Denial reasons are typically returned via X12 277/835 or CignaforHCP status updates. Cigna provides clear appeal pathways on its provider portal and in the Cigna Provider Manual, including peer-to-peer review options for clinical denials and expedited appeals for urgent care.
Frequently asked questions
How do I determine if Ultomiris requires prior authorization under Cigna Healthcare?
All specialty medications, including Ultomiris, typically require prior authorization under Cigna Healthcare. You should always verify specific member benefits and coverage policies on CignaforHCP.com or through your Klivira integration to confirm PA requirements based on the specific plan and benefit design (medical vs. pharmacy).
Which Cigna entity handles Ultomiris prior authorizations for pharmacy benefits?
For pharmacy benefit Ultomiris prior authorizations, Evernorth's Express Scripts manages the process. If Ultomiris is a specialty injectable, Accredo, also under Evernorth, will be the specialty pharmacy responsible for handling the prior authorization and dispensing.
Can I submit Ultomiris prior authorizations electronically to Cigna?
Yes, Cigna Healthcare accepts X12 278 transactions for medical benefit PAs. For pharmacy benefit PAs managed by Express Scripts, electronic submissions are well-established through ePA partners like CoverMyMeds and Surescripts. Klivira facilitates these electronic submission pathways for efficiency.
What are common reasons for Cigna Ultomiris prior authorization denials?
Common denial reasons include a lack of documented medical necessity, failure to meet step therapy requirements, insufficient clinical information, site-of-service discrepancies, or issues related to the Express Scripts formulary. Ensuring thorough documentation aligned with Cigna's coverage policies is crucial.
Where can I find Cigna's medical necessity criteria for Ultomiris?
Cigna Healthcare publishes its medical necessity criteria and coverage policies on its public provider site. These policies are versioned and dated, and it is essential to reference the specific policy number and effective date relevant to your submission for Ultomiris.
Related coverage
Other ultomiris prior authorization by payer
- Optimizing Aetna Ultomiris Prior Authorization Workflows
- Navigating Anthem (Elevance Health) Ultomiris Prior Authorization
- Streamlining Humana Ultomiris Prior Authorization Workflows
- Streamlining Medicaid Ultomiris Prior Authorization Workflows
- Streamlining Medicare Ultomiris Prior Authorization
- Navigating UnitedHealthcare Ultomiris Prior Authorization
Other ultomiris prior authorization by specialty
Ready to automate prior auth for this drug?
See how Klivira automates prior authorizations for your team.
Request a demo